NAVINTA LLC FDA Approval ANDA 207366

ANDA 207366

NAVINTA LLC

FDA Drug Application

Application #207366

Documents

Letter2016-10-14

Application Sponsors

ANDA 207366NAVINTA LLC

Marketing Status

Prescription001

Application Products

001FOR SOLUTION;INHALATION6GM/VIAL0RIBAVIRINRIBAVIRIN

FDA Submissions

UNKNOWN; ORIG1AP2016-10-06STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAN

CDER Filings

NAVINTA LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 207366
            [companyName] => NAVINTA LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"RIBAVIRIN","activeIngredients":"RIBAVIRIN","strength":"6GM\/VIAL","dosageForm":"FOR SOLUTION;INHALATION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/06\/2016","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2016\\\/207366Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2016-10-06
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.